What analysts say about Precision BioSciences Inc. stock - Unprecedented profit potential - Autocar Professional
DTIL Stock | USD 4.84 0.22 4.76% |
About 55% of Precision BioSciences' institutional investors are presently thinking to get in. The analysis of overall sentiment of trading Precision BioSciences stock suggests that some investors are interested at this time. Precision BioSciences' investing sentiment shows overall attitude of investors towards Precision BioSciences.
Precision | Build AI portfolio with Precision Stock |
What analysts say about Precision BioSciences Inc. stock - Unprecedented profit potential Autocar Professional
Read at news.google.com
![]() |
Precision BioSciences Fundamental Analysis
We analyze Precision BioSciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Precision BioSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Precision BioSciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Precision BioSciences is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Precision BioSciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Precision BioSciences stock to make a market-neutral strategy. Peer analysis of Precision BioSciences could also be used in its relative valuation, which is a method of valuing Precision BioSciences by comparing valuation metrics with similar companies.
Peers
Precision BioSciences Related Equities
ALEC | Alector | 6.90 | ||||
HRTX | Heron Therapeuti | 3.43 | ||||
HOOK | Hookipa Pharma | 3.37 | ||||
QTTB | Q32 Bio | 2.59 | ||||
RNA | Avidity Biosciences | 2.46 | ||||
ABOS | Acumen Pharmaceuticals | 2.26 | ||||
GOSS | Gossamer Bio | 0.46 |
Check out Precision BioSciences Hype Analysis, Precision BioSciences Correlation and Precision BioSciences Performance. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.